SightGlass Vision announced today that it received CE Mark approval in Europe for its eyeglasses for slowing myopia progression in children. Palo Alto, Calif.-based SightGlass Vision touts its novel diffusion optics technology (DOT) spectacle lens products as the first of its kind to show success in a multi-center, randomized, controlled clinical trial to include options […]
sightglassvision
SightGlass Vision launches trial for pediatric myopia-controlling eyeglasses
Opthalmalogical device maker SightGlass Vision said yesterday that it launched a pivotal clinical trial exploring the use of its novel lenses designed to reduce the rate of progression in children between six and nine years old. The Palo Alto, Calif.-based company’s Cypress trial is a multicenter, double-blinded, randomized controlled clinical trial that aims to enroll […]